Deborah M. Autor sold $277K of Amneal Pharmaceuticals (AMRX)

Executed Nov 22 2024, disclosed Nov 25 2024, 3 days later.

Value, as filed

$277K

33,229 sh × $8.34

Executed

Nov 22 2024

the trade date, as filed

Disclosed

Nov 25 2024

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DA Deborah M. Autor Director profile →

Deborah M. Autor (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $467K of HIMS (16,773 sh × $27.85, as filed), executed Aug 18.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Deborah M. Autor in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $451K
34,819 sh × $12.94
Exec May 11
Filed May 12 · 5:30 PM ET